Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Five molecular elements identified as potential future targets for hair loss therapy.

Advanced male pattern baldness affects the back of the scalp, reducing hair follicles.

Autologous cellular micrografts improve hair density and thickness in the short term for androgenetic alopecia.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Different hair and scalp disorders cause hair loss or excess hair growth, with various treatments available depending on the specific condition.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Using scalp stem cells can improve hair transplants.

Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

Lipedematous scalp may be underdiagnosed and doesn't improve with finasteride.

Occipital hair follicles in male pattern baldness respond uniquely to testosterone, not androgen-insensitive.

Chronic scalp lesions with crusts and pus that heal with strong topical steroids suggest Erosive Pustular Dermatosis, confirmed by biopsy showing specific immune cells.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

Using minoxidil on balding scalps can stimulate hair regrowth and increase blood flow. It's an effective treatment for early hair loss.

PRP injections did not significantly improve hair growth.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

The Trichoscopy Derived Sinclair Scale offers a more accurate and reliable way to measure hair loss severity than the traditional visual method.

Heat and chemicals improve finasteride delivery to scalp and hair follicles, potentially enhancing treatment for hair loss.

Impaired autophagy may cause hair loss by triggering early catagen.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

Chronic scalp lesions with crusts and pus indicate Erosive Pustular Dermatosis, which is confirmed by biopsy and effectively treated with strong topical steroids.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Thai males with hair loss have lower hair density in the occipital scalp compared to other Asians.

Women with telogen effluvium should be tested first for vitamin and mineral deficiencies.

A teenager's hair with alternating white and dark bands, known as Pili annulati, is a genetic condition that is usually harmless and often considered attractive.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.